Literature DB >> 17976653

A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.

Douglas R Denney1, Sharon G Lynch, Brett A Parmenter.   

Abstract

BACKGROUND: The few controlled longitudinal studies of cognitive performance in MS patients all provide evidence of deterioration in at least a subset of the patients sampled. Only one of these studies has focused on primary progressive MS, and little attention has been paid to the specific domains of cognitive functioning that change over time. The present study examined three principal cognitive domains in samples of primary progressive MS patients and healthy controls followed over a period of 3 years.
METHODS: A battery of neuropsychological tests that included measures of strategic problem solving, verbal memory, and information processing speed was administered annually to 24 MS patients and 25 controls.
RESULTS: MS patients' performance on measures of processing speed showed significantly greater decline over the 3-year period than did that of controls. Similar results were not observed in the case of problem solving or verbal memory. There was no evidence of more dramatic decline occurring in patients who were initially classified as cognitively impaired relative to those who were unimpaired at baseline. However, this failure may have been influenced by differential attrition from the sample; more impaired patients were less likely to complete the study.
CONCLUSION: Overall the results support the contention that information processing speed is the domain most sensitive to the impact of multiple sclerosis on cognitive functioning over time.

Entities:  

Mesh:

Year:  2007        PMID: 17976653     DOI: 10.1016/j.jns.2007.10.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Cognitive impairment in early stages of multiple sclerosis.

Authors:  Maria Pia Amato; E Portaccio; B Goretti; V Zipoli; B Hakiki; M Giannini; L Pastò; L Razzolini
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

2.  Ecological Momentary Assessment of Pain, Fatigue, Depressive, and Cognitive Symptoms Reveals Significant Daily Variability in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

3.  Processing speed versus working memory: contributions to an information-processing task in multiple sclerosis.

Authors:  Helen M Genova; Jeannie Lengenfelder; Nancy D Chiaravalloti; Nancy B Moore; John DeLuca
Journal:  Appl Neuropsychol Adult       Date:  2012       Impact factor: 2.248

Review 4.  Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.

Authors:  Jan-Patrick Stellmann; Anneke Neuhaus; Christian Lederer; Martin Daumer; Christoph Heesen
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

5.  Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.

Authors:  Martina Borghi; Sara Carletto; Luca Ostacoli; Francesco Scavelli; Lorenzo Pia; Marco Pagani; Antonio Bertolotto; Simona Malucchi; Alessio Signori; Marco Cavallo
Journal:  Front Hum Neurosci       Date:  2016-06-08       Impact factor: 3.169

Review 6.  Recommendations for cognitive screening and management in multiple sclerosis care.

Authors:  Rosalind Kalb; Meghan Beier; Ralph Hb Benedict; Leigh Charvet; Kathleen Costello; Anthony Feinstein; Jeffrey Gingold; Yael Goverover; June Halper; Colleen Harris; Lori Kostich; Lauren Krupp; Ellen Lathi; Nicholas LaRocca; Ben Thrower; John DeLuca
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

7.  Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis.

Authors:  K H Lam; P van Oirschot; B den Teuling; H E Hulst; B A de Jong; Bmj Uitdehaag; V de Groot; J Killestein
Journal:  Mult Scler       Date:  2021-05-26       Impact factor: 6.312

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.